Back
Gold Fields Vs. Monopar Therapeutics Industry Stock Comparison
Buy
64
GFI
Gold Fields
Last Price:
$22.06
Seasonality Move:
-0.88%
Buy
53
MNPR
Monopar Therapeutics
Last Price:
$41.39
Seasonality Move:
-14.17%
Buy
64
Gold Fields (GFI)
is a Buy
Is Gold Fields a Buy, Sell or Hold?
-
The current Gold Fields [GFI] share price is $20.96. The Score for GFI is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
-
GFI is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
53
Monopar Therapeutics (MNPR)
is a Buy
Is Monopar Therapeutics a Buy, Sell or Hold?
-
The current Monopar Therapeutics [MNPR] share price is $41.39. The Score for MNPR is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
-
MNPR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
GFI Stock Price Chart
What is Gold Fields's stock price today?
-
The Gold Fields share price today is $20.96Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GFI is experiencing buying pressure, which is a positive indicator for future bullish movement.
MNPR Stock Price Chart
What is Monopar Therapeutics's stock price today?
-
The Monopar Therapeutics share price today is $41.39Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MNPR is experiencing slight buying pressure.
GFI Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.74 | Buy |
Relative Strength Index (14 RSI): | 58.86 | Buy |
Chaikin Money Flow: | 3282543 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (18.85 - 21.09) | Buy |
Bollinger Bands (100): | (14.05 - 19.09) | Buy |
MNPR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.85 | Buy |
Relative Strength Index (14 RSI): | 58.68 | Buy |
Chaikin Money Flow: | 12278 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (29.98 - 39.9) | Buy |
Bollinger Bands (100): | (19.38 - 39.44) | Buy |
GFI Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 21.18 | Sell |
20-day SMA: | 20.22 | Buy |
50-day SMA: | 18.57 | Buy |
200-day SMA: | 16.07 | Buy |
8-day EMA: | 20.87 | Buy |
20-day EMA: | 20.33 | Buy |
50-day EMA: | 18.84 | Buy |
200-day EMA: | 16.5 | Buy |
MNPR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 39.11 | Buy |
20-day SMA: | 34.28 | Buy |
50-day SMA: | 37.57 | Buy |
200-day SMA: | 16.87 | Buy |
8-day EMA: | 38.3 | Buy |
20-day EMA: | 36.79 | Buy |
50-day EMA: | 34.94 | Buy |
200-day EMA: | 21.55 | Buy |
Gold Fields Earnings Growth & GFI Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.16 per share, an increase next quarter of $0.02 per share, an increase this year of $0.53 per share, and an increase next year of $0.36 per share.
Monopar Therapeutics Earnings Growth & MNPR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.50 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.70 per share, and an increase next year of $2.24 per share.
Gold Fields Technical Analysis
Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
14 | 17 | 18 | 19 | 20 | 21 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Monopar Therapeutics Technical Analysis
Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
14 | 17 | 18 | 19 | 20 | 21 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |